The weight-loss properties of GLP-1 drugs, including Ozempic and Wegovy, have dominated headlines. But could they also cut alcohol consumption? And what would this mean for beverage manufacturers? The ...

A man drinking a glass of whisky. Image by Tim Sandle. A man drinking a glass of whisky. Image by Tim Sandle. A new joint study by the University of Eastern Finland and Karolinska Institutet in Sweden ...

GLP-1 drugs, originally developed for diabetes and obesity, may also curb addictive behaviors by acting on reward circuits in the brain. Early trials show reductions in alcohol intake, opioid seeking, ...

Popular drugs credited with shrinking waistlines and controlling blood sugar may also take the edge off alcohol’s buzz, according to a new study. Researchers at Virginia Tech's Fralin Biomedical ...

An ingredient in the prescription diabetes drug Mounjaro was found to reduce alcohol intake in rodents, according to a recent study. In the study, published in early January in the medical journal ...

Shalini Arunogiri receives funding from the National Health and Medical Research Council for projects unrelated to this work (NHMRC Investigator Grant: GNT2008193 and several NHMRC clinical trial ...

Several research studies, either in progress or in planning stages, are testing whether GLP-1 agonists can help people who have symptoms of an alcohol use disorder reduce drinking. The goal of the ...